Stockscreener 앱 받기
10.39
2.44%
-0.26
시간 외 거래:
10.39
전일 마감가:
$10.65
열려 있는:
$10.76
하루 거래량:
190.15K
Relative Volume:
1.04
시가총액:
$224.69M
수익:
-
순이익/손실:
$-35.46M
주가수익비율:
-24.63
EPS:
-0.4218
순현금흐름:
$-34.00M
1주 성능:
-5.80%
1개월 성능:
-8.46%
6개월 성능:
+153.41%
1년 성능:
-37.26%
1일 변동 폭
$10.15
$11.30
1주일 범위
$10.15
$11.30
52주 변동 폭
$3.35
$20.24
Contineum Therapeutics Inc Stock (CTNM) Company Profile
명칭
Contineum Therapeutics Inc
전화
(858) 333-5280
주소
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO
CTNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTNM
Contineum Therapeutics Inc
|
10.39 | 310.79M | 0 | -35.46M | -34.00M | -0.4218 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Contineum Therapeutics Inc Stock (CTNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-25 | 개시 | Leerink Partners | Outperform |
| 2025-06-20 | 개시 | William Blair | Outperform |
| 2024-10-22 | 개시 | Robert W. Baird | Outperform |
| 2024-04-30 | 개시 | Morgan Stanley | Overweight |
| 2024-04-30 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-30 | 개시 | Stifel | Buy |
모두보기
Contineum Therapeutics Inc 주식(CTNM)의 최신 뉴스
Real time social sentiment graph for Contineum Therapeutics Inc.2025 Growth vs Value & Long-Term Growth Plans - newser.com
Can Contineum Therapeutics Inc. stock outperform in 2025 bull market2025 Market Trends & Expert Curated Trade Ideas - newser.com
Will Contineum Therapeutics Inc. stock benefit from automationWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Is it time to cut losses on Contineum Therapeutics Inc.2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
What momentum shifts mean for Contineum Therapeutics Inc.Buy Signal & Reliable Volume Spike Trade Alerts - newser.com
Building trade automation scripts for Contineum Therapeutics Inc.Quarterly Trade Report & Technical Entry and Exit Tips - newser.com
Using Ichimoku Cloud for Contineum Therapeutics Inc. technicalsQuarterly Growth Report & Detailed Earnings Play Alerts - newser.com
Live market analysis of Contineum Therapeutics Inc.Market Growth Report & Risk Managed Investment Entry Signals - newser.com
Why retail investors pile into Contineum Therapeutics Inc. stockWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com
Why Contineum Therapeutics Inc. stock could see breakout soonJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
How Contineum Therapeutics Inc. stock reacts to inflationary pressuresWeekly Trade Report & Free Safe Capital Growth Stock Tips - newser.com
Risk adjusted return profile for Contineum Therapeutics Inc. analyzedBond Market & Fast Entry Momentum Trade Alerts - newser.com
Contineum Therapeutics Inc. stock momentum explained2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
How Contineum Therapeutics Inc. stock compares to growth peersEntry Point & Scalable Portfolio Growth Ideas - newser.com
Volatility clustering patterns for Contineum Therapeutics Inc.July 2025 Breakouts & AI Optimized Trade Strategies - newser.com
Will Contineum Therapeutics Inc. stock split attract more investors2025 Major Catalysts & Consistent Profit Alerts - newser.com
Contineum Therapeutics (NASDAQ:CTNM) Issues Quarterly Earnings Results - MarketBeat
Using data models to predict Contineum Therapeutics Inc. stock movementPortfolio Gains Report & Daily Technical Stock Forecast Reports - newser.com
Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities - TipRanks
Is Contineum Therapeutics Inc. building a consolidation baseWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
What makes RF Acquisition Corp II stock price move sharply - newser.com
Contineum Therapeutics Inc (CTNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):